BANK VONTOBEL/CALL/WALGREENS BOOTS ALLIANCE/23/0.1/21.06.24 Stock

Warrant

DE000VM14VR7

Delayed Deutsche Boerse AG 11:04:53 2024-06-18 am EDT
0.001 EUR 0.00% Intraday chart for BANK VONTOBEL/CALL/WALGREENS BOOTS ALLIANCE/23/0.1/21.06.24
3 months-98.98%
6 months-99.75%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-18 0.001 0.00%
24-06-17 0.001 0.00%
24-06-14 0.001 0.00%
24-06-13 0.001 0.00%
24-06-12 0.001 0.00%

Delayed Quote Deutsche Boerse AG

Last update June 18, 2024 at 11:04 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying WALGREENS BOOTS ALLIANCE, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM14VR
ISINDE000VM14VR7
Date issued 2023-09-06
Strike 23 $
Maturity 2024-06-21 (3 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.51
Lowest since issue 0.001
Spread 0.019
Spread %95.00%

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Sector
-
More about the company

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Walgreens Boots Alliance, Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
15.15 USD
Average target price
22.21 USD
Spread / Average Target
+46.59%
Consensus